Acta Scientific Biotechnology (ASBT)

Editorial Volume 1 Issue 3

Pharmacogenomics-A Step Towards the Individualized Medicine

Kanwal Ashiq*

Faculty of Pharmaceutical Sciences Superior College, Superior University Lahore, Pakistan

*Corresponding Author: Kanwal Ashiq, Faculty of Pharmaceutical Sciences Superior College, Superior University 17-km Raiwind Road Lahore, Pakistan.

Received: January 17, 2020; Published: February 01, 2020

×

Abstract

  Pharmacogenomics is relatively a young discipline of science which focuses on the impact of human genetic variations on drug response. The field of Pharmacogenomics is an amalgamation of the two science areas i.e. pharmacology and genomic with an aim at personalizing individual medicine. With clinical practice and drug development, individual drug response variation is faced as a major challenge in terms of drug safety and efficacy [1].

  The concept that genetic changes may lead to variable drug response was brought forth in late 20th century. However, recently Pharmacogenomics is pacing beyond the scope of solitary gene making up to multiple genes, possibly causing varying drug response [2].

×

Citation

Citation: Kanwal Ashiq. “Pharmacogenomics-A Step Towards the Individualized Medicine".Acta Scientific Biotechnology 1.3 (2020): 01-02.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US